Tumor Promotion by Depleting Cells of Protein Kinase Cδ
Open Access
- 1 June 1997
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 17 (6) , 3418-3428
Abstract
Tumor-promoting phorbol esters activate, but then deplete cells of, protein kinase C (PKC) with prolonged treatment. It is not known whether phorbol ester-induced tumor promotion is due to activation or depletion of PKC. In rat fibroblasts overexpressing the c-Src proto-oncogene, the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) induced anchorage-independent growth and other transformation-related phenotypes. The appearance of transformed phenotypes induced by TPA in these cells correlated not with activation but rather with depletion of expressed PKC isoforms. Consistent with this observation, PKC inhibitors also induced transformed phenotypes in c-Src-overexpressing cells. Bryostatin 1, which inhibited the TPA-induced down-regulation of the PKCdelta isoform specifically, blocked the tumor-promoting effects of TPA, implicating PKCdelta as the target of the tumor-promoting phorbol esters. Consistent with this hypothesis, expression of a dominant negative PKCdelta mutant in cells expressing c-Src caused transformation of these cells, and rottlerin, a protein kinase inhibitor with specificity for PKCdelta, like TPA, caused transformation of c-Src-overexpressing cells. These data suggest that the tumor-promoting effect of phorbol esters is due to depletion of PKCdelta, which has an apparent tumor suppressor function.Keywords
This publication has 49 references indexed in Scilit:
- Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptorsNature, 1996
- Phosphoinositide-specific phospholipase C and mitogenic signalingBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1995
- Involvement of Ral GTPase in v-Src-induced phospholipase D activationNature, 1995
- Protein kinase C inhibitors induce apoptosis in human malignant glioma cell linesFEBS Letters, 1994
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994
- Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesisNature, 1992
- Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesisNature, 1992
- Multistage carcinogenesis in mouse skinPharmacology & Therapeutics, 1992
- PDGF-Induced Activation of Phospholipase C Is Not Required for Induction of DNA SynthesisScience, 1990
- Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skinCarcinogenesis, 1987